Leap Technologies and Antec Announce HDX–MS Venture
Leap Technologies Inc. and Antec have announced a joint venture in the field of sample preparation for HDX–MS.
Leap Technologies Inc. (Carrboro, USA) and Antec (Zoeterwoude, The Netherlands) have announced a joint venture in the field of sample preparation for hydrogen deuterium exchangeâmass spectrometry (HDXâMS).
“We are excited to collaborate with LEAP the world leader in HDX automation and to bring HDX/MS to a new level of customer satisfaction by integrating the disulfide bond reduction,” said Jean-Pierre Chervet, CEO of Antec.
The integration of Leap Technologies’ automated workstation with Antec’s electrochemical mass spectrometry system will provide a fully automated hydrogen deuterium exchange electrochemical mass spectrometry workflow that can be used with mass spectrometers.
This full integration decreases the time required to reduce the disulphide bonds in proteins/peptides when using reducing agents such as TCEP. This is particularly useful for large and highly disupfide-stabilised proteins, enabling HDX analysis and resulting in increased overall sequence coverage.
Leap and Antec will be presenting this approach at the American Society for Mass Spectrometry conference (ASMS) in San Antonio, Texas, USA, June 5â9.
For more information about Antec visit www.myantec.com
For more information about Leap Technologies visit www.leaptec.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
